Pharmacologic treatment of attention deficit hyperactivity disorder

Psychiatr Clin North Am. 1992 Mar;15(1):1-27.

Abstract

This article describes the role of psychostimulant medication in the treatment of attention deficit hyperactivity disorder. Included are the drugs' putative mechanisms of action, pharmacology, toxicology, indications for their use, short-term and long-term actions, adverse effects, specific dosing regimens, therapeutic monitoring techniques, alternative medications, and drug interactions.

Publication types

  • Review

MeSH terms

  • Attention Deficit Disorder with Hyperactivity / drug therapy*
  • Attention Deficit Disorder with Hyperactivity / metabolism
  • Attention Deficit Disorder with Hyperactivity / psychology
  • Central Nervous System Stimulants / adverse effects
  • Central Nervous System Stimulants / metabolism
  • Central Nervous System Stimulants / therapeutic use*
  • Child
  • Child, Preschool
  • Clonidine / adverse effects
  • Clonidine / therapeutic use
  • Desipramine / adverse effects
  • Desipramine / therapeutic use
  • Female
  • Humans
  • Male
  • Methylphenidate / metabolism
  • Methylphenidate / therapeutic use

Substances

  • Central Nervous System Stimulants
  • Methylphenidate
  • Clonidine
  • Desipramine